nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—HRH1—Histamine receptors—HRH3—narcolepsy	0.181	0.181	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0281	0.0281	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0277	0.0277	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Other—P2RY11—narcolepsy	0.0259	0.0259	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.0167	0.0167	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—HTR2A—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0153	0.0153	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0153	0.0153	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0148	0.0148	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.014	0.014	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0138	0.0138	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00997	0.00997	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00997	0.00997	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00978	0.00978	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00963	0.00963	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.00952	0.00952	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00918	0.00918	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00851	0.00851	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00832	0.00832	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00818	0.00818	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00787	0.00787	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.00771	0.00771	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.00771	0.00771	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00759	0.00759	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00759	0.00759	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.00745	0.00745	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00741	0.00741	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00733	0.00733	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0073	0.0073	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00728	0.00728	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.00692	0.00692	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.00692	0.00692	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00684	0.00684	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00645	0.00645	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00635	0.00635	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00633	0.00633	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0062	0.0062	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00619	0.00619	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00619	0.00619	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00565	0.00565	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00544	0.00544	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—TRH—narcolepsy	0.0048	0.0048	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00472	0.00472	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00458	0.00458	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00458	0.00458	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00429	0.00429	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00429	0.00429	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00421	0.00421	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00421	0.00421	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00416	0.00416	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00414	0.00414	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00414	0.00414	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00396	0.00396	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00396	0.00396	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00389	0.00389	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00389	0.00389	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00376	0.00376	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00372	0.00372	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00352	0.00352	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—NPS—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00325	0.00325	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00322	0.00322	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PENK—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00242	0.00242	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HCRT—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—NPS—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PENK—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PENK—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TRH—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRH3—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NPS—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TAC1—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.000636	0.000636	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000626	0.000626	CbGpPWpGaD
